Kapoor et al., 2011, (13) concluded in a study of 41 patients with non-metastatic cancer prostate patients on ADT, that 3 monthly administration of Zoledronic acid for 1 year improved vertebral and left femoral neck BMD in men on GnRH-agonist treatment. Here, GNRH1 is linked to metastatic malignant neoplasm.